Revision: March 11, 2020, 3:34 p.m.
HB 1424 - AS AMENDED BY THE HOUSE
11Mar2020... 0630h
2020 SESSION
20-2298
01/04
HOUSE BILL 1424
SPONSORS: Rep. W. Thomas, Hills. 21; Rep. Conley, Straf. 13; Rep. DesMarais, Carr. 6; Rep. Josephson, Graf. 11; Rep. Coursin, Rock. 1; Rep. Stack, Hills. 21; Rep. Cannon, Straf. 18; Rep. Amanda Bouldin, Hills. 12; Rep. Kenney, Straf. 6
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill allows alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
11Mar2020... 0630h 20-2298
01/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Paragraph; Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers; Requirements. Amend RSA 126-X:8 by inserting after paragraph XVIII the following new paragraph:
XIX. An alternative treatment center may acquire, and may use in the manufacture of cannabis concentrate and cannabis infused products, hemp-derived cannabidiol, or CBD, isolate that is not produced by an alterative treatment center in New Hampshire. All such CBD isolate, and all cannabis concentrate and cannabis infused products manufactured from such CBD isolate, shall be tested for contaminants and cannabinoid profile in accordance with this chapter and department rules.
2 Effective Date. This act shall take effect 60 days after its passage.